The new prostate cancer blood test with 94 per cent accuracy
Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods.
New research shows that the Prostate Screening EpiSwitch (PSE) blood test is 94 per cent accurate – beating the currently used prostate-specific antigen (PSA) blood test.
The research team say that the new test shows significant potential as an accurate and rapid cancer screening diagnostic.



















